Article Text

Download PDFPDF
Human Papillomavirus DNA Presence in Pelvic Lymph Nodes in Cervical Cancer
  1. Jiri Slama, MD, PhD,
  2. Daniela Fischerova, MD, PhD,
  3. Ivana Pinkavova, MD,
  4. Michal Zikan, MD, PhD and
  5. David Cibula, MD, PhD
  1. Department of Oncogynecology, General Teaching Hospital and 1st Medical School of Charles University, Prague 2, Czech Republic.
  1. Address correspondence and reprint requests to Jiri Slama, MD, PhD, Department of Oncogynecology, General Teaching Hospital and 1st Medica School of Charles University, Apolinarska 18, 128 00 Prague 2, Czech Republic. E-mail: slamajiri{at}


Introduction: This work intends to present a systematic overview of data that have been published so far with regard to methods used for tissue sampling and DNA testing and with regard to the prevalence of human papillomavirus (HPV) DNA in pelvic lymph nodes (LNs) and its prognostic significance.

Methods: The HPV DNA status of LN in women with cervical cancer is being explored as a potential marker of "occult" metastases. Although the presence of HPV DNA in LN usually correlates with its metastatic involvement, there is always a subgroup of HPV-positive but histologically negative LNs.

Results: The significance of HPV in negative LNs remains uncertain, although several studies have concluded that HPV is a risk factor of recurrence.

Conclusions: A small group size and a short follow-up are the main limitations for drawing any conclusion concerning prognostic significance of the presence of HPV DNA in LNs.

  • Cervical cancer
  • HPV
  • Lymph node
  • Prognostic significance
  • Sentinel lymph node
  • Recurrence

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.